Never in the history of IASLC has so much been presented to so many by so few in such a short time window #WCLC19

Brilliant presentation by our very own Prof Gary Middleton on the first results from the National Lung Matrix Trial #lungmatrix at the World Conference on Lung Cancer #WCLC19 - the team from Birmingham Cancer Research UK Clinical Trials Unit are very proud!

Here are the first results of the National Lung Matrix Trial (NLMT), presented by Prof. Gary Middleton at the #WCLC19 symposium. Are some of these poor targets potentially good targets? Cancer Research UK #LCSM

Off to do the CRUK CTU bikeathon - check out the web page and any donations very welcome! #CTUBikeathon @CRUKBirmingham & Midlands https:/fundraise.cancerresearchuk.org/unite/the-clinical-trials-bikeathon

Birmingham team successfully complete the #CTUBikeathon @CRUKBirmingham & Midlands

Birmingham's very own Prof Gary Middleton giving the BTOG community a rapid overview of lessons learned in the National Lung Matrix Trial BTOG Birmingham Cancer Research UK Clinical Trials Unit #BTOG20

Great end to first day of the BTOG 2020 conference with John Humphrys hosting the debate about how to treat stage III NSCLC BTOG John Humphrys #BTOG20

It is such a privilege to be Chief Biostatistician for #NationalLungMatrixTrial and so exciting to work with Trial Statistician Peter Fletcher Peter Fletcher and the brilliant national team of investigators led by Gary Middleton to deliver these first Bayesian results

Our wonderful Lucinda Billingham is presenting on the Cancer Research UK sponsored DETERMINE trial, with CRUK Manchester Institute CI Matt Krebbs, Birmingham Cancer Research UK Clinical Trials Unit methodology leadership and @unibirm_MDS translational leadership - wonderful example of collaboration

Our fantastic statistician Amit Patel presenting our ADePT DDR trial - wonderful example of innovative early phase trial design

Great talk from Prof Deborah Stocken PhD at #ICTMC2022 on In Silico Clinical Trials - definitely an interesting concept to take back to Birmingham Cancer Research UK Clinical Trials Unit

statistician Laura Kirton's excellent presentation of an innovative design tool to continuously monitor efficacy outcomes in rare diseases , such as #MonoGerm trial of carboplatin or vinblastine monotherapy in paediatric intracranial germinoma Lucinda Billingham #ICTMC2022

Rhabdomyosarcoma is a soft tissue cancer that mostly affects young children. Collaboration in research is vital to save young lives. FaR-RMS trial is led by Meriel Jenney and funded by Science and Innovation at Cancer Research UK #childhoodcancer #clinicaltrials

Prof Lucinda Billingham from Uni of Birmingham is leading the CAPTIVATE node, with colleagues from The University of Sheffield & University of Liverpool. Reimagining how clinical trials for rare diseases are designed to enable results despite low numbers. Funded by Medical Research Council & National Institute for Health and Care Research. birmingham.ac.uk/news/2023/rare…

Prof Lucinda Billingham and Victoria, from Cancer and Genomic Sciences, tell us more about how the CAPTIVATE node is reimagining the way we design clinical trials for rare diseases, to enable results despite low numbers. Working with The University of Sheffield & University of Liverpool and funded by Medical Research Council & National Institute for Health and Care Research. x.com/unibirm_MDS/st…

Welcome to Professor Amos Burke, who was recently appointed Director of the Birmingham Cancer Research UK Clinical Trials Unit Birmingham Cancer Research UK Clinical Trials Unit Cancer and Genomic Sciences birmingham.ac.uk/news/2023/prof… pic.x.com/c8eUoFiIgX

We are delighted to announce that the 2025 BTOG Lifetime Achievement Award has been presented to Professor Lucinda Billingham. The announcement was made by Professor Gary MIddleton with a heartfelt speech and hosted at the 23nd BTOG Annual Conference in Belfast by Professor

🌟Lucinda Billingham Receives the 2025 BTOG Lifetime Achievement Award🏆 Lucinda Billingham The British Thoracic Oncology Group (BTOG) has awarded Lucinda Billingham the 2025 BTOG Lifetime Achievement Award for her contributions to thoracic oncology in the UK.🫁 The award